NEW YORK (GenomeWeb News) – Accelr8 said today that it has begun a private sale of equity to qualified investors. The company first announced the equity offer following its annual shareholders' meeting on Dec. 16.

Accler8 also provided updates on several recent corporate events, including that of a "going concern" statement by its auditors attributed to recurring losses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.